Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Haraldsen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Quality Assurance Network Newsletter|October 5, 1994
Concerted action on qualityK Bjoro, E Bjornsborg, B Haraldsen
Medical Devices (Auckland, N.Z.)|August 14, 2018
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birthMichael N Travanty, Bryon Calawa, Waleed S Shalaby, et al.
European Heart Journal Open|March 16, 2026
Cardiac-related symptoms in individuals aged ≥65 years without diagnosed cardiac disease: insights from the NORSCREEN trialJarle Jortveit, Miroslav Boskovic, Marius B Haraldsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 25, 2026
Interrater agreement in atrial fibrillation diagnosis using one-week single-lead patch ECG monitoring: Findings from the NORSCREEN trialMarius B Haraldsen, Miroslav Boskovic, Trygve Berge, et al.
Current Biology : CB|October 16, 2018
Unicellular Origin of the Animal MicroRNA MachineryJon Bråte, Ralf S Neumann, Bastian Fromm, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Quality Assurance Network Newsletter|October 5, 1994
Concerted action on qualityK Bjoro, E Bjornsborg, B Haraldsen
Medical Devices (Auckland, N.Z.)|August 14, 2018
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birthMichael N Travanty, Bryon Calawa, Waleed S Shalaby, et al.
European Heart Journal Open|March 16, 2026
Cardiac-related symptoms in individuals aged ≥65 years without diagnosed cardiac disease: insights from the NORSCREEN trialJarle Jortveit, Miroslav Boskovic, Marius B Haraldsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 25, 2026
Interrater agreement in atrial fibrillation diagnosis using one-week single-lead patch ECG monitoring: Findings from the NORSCREEN trialMarius B Haraldsen, Miroslav Boskovic, Trygve Berge, et al.
Current Biology : CB|October 16, 2018
Unicellular Origin of the Animal MicroRNA MachineryJon Bråte, Ralf S Neumann, Bastian Fromm, et al.
Pageof 1